dapsone has been researched along with Red-Cell Aplasia, Pure in 1 studies
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borrás-Blasco, J | 1 |
| Conesa-García, V | 1 |
| Navarro-Ruiz, A | 1 |
| Devesa, P | 1 |
| Matarredona, J | 1 |
| Marín-Jiménez, F | 1 |
1 other study available for dapsone and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Pure red cell aplasia associated with dapsone therapy.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Transfusion; Dapsone; Gra | 2005 |